JP2005514010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514010A5 JP2005514010A5 JP2003536272A JP2003536272A JP2005514010A5 JP 2005514010 A5 JP2005514010 A5 JP 2005514010A5 JP 2003536272 A JP2003536272 A JP 2003536272A JP 2003536272 A JP2003536272 A JP 2003536272A JP 2005514010 A5 JP2005514010 A5 JP 2005514010A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- composition
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 23
- 229920001184 polypeptide Polymers 0.000 claims 22
- 102000004196 processed proteins & peptides Human genes 0.000 claims 22
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 150000001413 amino acids Chemical group 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 101150112998 ADIPOQ gene Proteins 0.000 claims 3
- 101150096655 APM1 gene Proteins 0.000 claims 3
- 101100162826 Dictyostelium discoideum apm2 gene Proteins 0.000 claims 3
- 101100053794 Homo sapiens ZBTB7C gene Proteins 0.000 claims 3
- 102100023250 Zinc finger and BTB domain-containing protein 7C Human genes 0.000 claims 3
- 230000037396 body weight Effects 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 235000021588 free fatty acids Nutrition 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 230000004584 weight gain Effects 0.000 claims 1
- 235000019786 weight gain Nutrition 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32907401P | 2001-10-12 | 2001-10-12 | |
| PCT/IB2002/004635 WO2003033534A2 (en) | 2001-10-12 | 2002-10-03 | Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005514010A JP2005514010A (ja) | 2005-05-19 |
| JP2005514010A5 true JP2005514010A5 (enExample) | 2005-12-22 |
Family
ID=23283741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003536272A Pending JP2005514010A (ja) | 2001-10-12 | 2002-10-03 | Ｎｇｚｉｐａ、ｎｇｚｉｐｄ、ｐｇｚｉｐａおよびｐｇｚｉｐｄポリヌクレオチドおよびポリペプチド、ならびにその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050065079A1 (enExample) |
| EP (1) | EP1436326A2 (enExample) |
| JP (1) | JP2005514010A (enExample) |
| AU (1) | AU2002339686B2 (enExample) |
| CA (1) | CA2462588A1 (enExample) |
| IL (1) | IL161234A0 (enExample) |
| WO (1) | WO2003033534A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7223727B2 (en) * | 1998-04-09 | 2007-05-29 | Serono Genetics Institute S.A. | GSSP4 polynucleotides and polypeptides and uses thereof |
| ATE464378T1 (de) * | 2000-05-31 | 2010-04-15 | Serono Genetics Inst Sa | Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung |
| WO2003050281A2 (en) * | 2001-10-05 | 2003-06-19 | Genset S.A. | Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity |
| ATE478890T1 (de) | 2002-05-31 | 2010-09-15 | Serono Genetics Inst Sa | Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon |
| EA201270574A1 (ru) * | 2009-10-19 | 2012-12-28 | Ростакуо С.П.А. | Способы и системы для фармакогеномного лечения сердечно-сосудистых заболеваний |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9811465D0 (en) * | 1998-05-29 | 1998-07-29 | Tisdale Michael J | Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
-
2002
- 2002-10-03 WO PCT/IB2002/004635 patent/WO2003033534A2/en not_active Ceased
- 2002-10-03 AU AU2002339686A patent/AU2002339686B2/en not_active Ceased
- 2002-10-03 US US10/492,179 patent/US20050065079A1/en not_active Abandoned
- 2002-10-03 CA CA002462588A patent/CA2462588A1/en not_active Abandoned
- 2002-10-03 IL IL16123402A patent/IL161234A0/xx unknown
- 2002-10-03 EP EP02777735A patent/EP1436326A2/en not_active Withdrawn
- 2002-10-03 JP JP2003536272A patent/JP2005514010A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2270042A3 (en) | KDR peptides and vaccines comprising the same | |
| ATE378407T1 (de) | Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen | |
| JP2004536614A5 (enExample) | ||
| JP2000312590A5 (enExample) | ||
| IL210455A (en) | A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals | |
| JP2001511347A5 (enExample) | ||
| CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
| JP2005514010A5 (enExample) | ||
| DE60313982D1 (de) | Dimere von thrombinpeptidderivaten | |
| JP2005511088A5 (enExample) | ||
| JP2004535161A5 (enExample) | ||
| JP2003334088A5 (enExample) | ||
| EP1065214A4 (en) | NEW, PHYSIOLOGICALLY ACTIVE PEPTIDES AND THEIR USE. | |
| WO2003038061A3 (en) | Ehrlichia disulfide bond formation proteins and uses thereof | |
| WO1998004585A3 (en) | Novel human macrophage antigen | |
| ATE375390T1 (de) | G-protein-gekoppelter rezeptor-ähnliche proteine | |
| JP2005097237A5 (enExample) | ||
| JP2003523186A5 (enExample) | ||
| JP2005501524A5 (enExample) | ||
| JP2006158244A5 (enExample) | ||
| JP2003529360A5 (enExample) | ||
| JPH1189577A5 (enExample) | ||
| CA2404688A1 (en) | Nuclear factor .kappa.b inducing factor | |
| WO2003027255A3 (en) | Anti-fusion assay | |
| JP2001321186A5 (enExample) |